Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
Fiche publication
Date publication
février 2016
Journal
The Journal of antimicrobial chemotherapy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DUVILLARD Laurence
Tous les auteurs :
Piroth L, Moinot L, Yeni P, Avettand-Fénoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chêne G, Fagard C,
Lien Pubmed
Résumé
The objective of this study was to assess clinical and biological changes during intermittent ART (I-ART) started early, with significant time spent on versus off ART, which has never before been studied in ART-naive patients with high nadir and current CD4 cell count.
Mots clés
Antiretroviral Therapy, Highly Active, methods, CD4 Lymphocyte Count, HIV Infections, drug therapy, HIV-1, immunology, Inflammation, pathology, Viral Load
Référence
J. Antimicrob. Chemother.. 2016 Feb;71(2):490-6